• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生活健康技术评估:问题、挑战与机遇。

Living Health Technology Assessment: Issues, Challenges and Opportunities.

机构信息

School of Health and Related Research, The University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, UK.

ConnectHEOR Ltd, London, UK.

出版信息

Pharmacoeconomics. 2023 Mar;41(3):227-237. doi: 10.1007/s40273-022-01229-4. Epub 2023 Jan 18.

DOI:10.1007/s40273-022-01229-4
PMID:36652184
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9848020/
Abstract

Health technology assessments (HTAs) are typically performed as one-off evaluations and can potentially become out-of-date due to the availability of new data, new comparators, or other factors. Recently, living approaches have been applied to systematic reviews and network meta-analyses to enable evidence syntheses to be updated more easily. In this paper, we provide a definition for 'Living HTA' where such a living approach could be applied to the entire HTA process. Living HTA could involve performing regular or scheduled updates using a traditional manual approach, or indeed in a semi-automated manner leveraging recent technological innovations that automate parts of the HTA process. The practical implementation of living HTA using both approaches (i.e., manual approach and using semi-automation) is described along with the likely issues and challenges with planning and implementing a living HTA process. The time, resources and additional considerations outlined may prohibit living HTA from becoming the norm for every evaluation; however, scenarios where living HTA would be particularly beneficial are discussed.

摘要

健康技术评估(HTA)通常作为一次性评估进行,由于新数据、新对照物或其他因素的出现,可能会变得过时。最近,人们采用了动态方法来进行系统评价和网络荟萃分析,以便更轻松地更新证据综合。在本文中,我们提供了“动态 HTA”的定义,其中可以将这种动态方法应用于整个 HTA 过程。动态 HTA 可能涉及使用传统的手动方法定期或定期进行更新,或者实际上以半自动化的方式利用最近的技术创新来自动化 HTA 过程的部分环节。描述了使用这两种方法(即手动方法和使用半自动化)实施动态 HTA 的实际操作,以及规划和实施动态 HTA 过程中可能出现的问题和挑战。概述的时间、资源和其他考虑因素可能会阻止动态 HTA 成为每个评估的标准;然而,讨论了特别有利于动态 HTA 的情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b51/9848020/77fd6729629c/40273_2022_1229_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b51/9848020/102c37ba0add/40273_2022_1229_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b51/9848020/3784805a65bf/40273_2022_1229_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b51/9848020/77fd6729629c/40273_2022_1229_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b51/9848020/102c37ba0add/40273_2022_1229_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b51/9848020/3784805a65bf/40273_2022_1229_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b51/9848020/77fd6729629c/40273_2022_1229_Fig3_HTML.jpg

相似文献

1
Living Health Technology Assessment: Issues, Challenges and Opportunities.生活健康技术评估:问题、挑战与机遇。
Pharmacoeconomics. 2023 Mar;41(3):227-237. doi: 10.1007/s40273-022-01229-4. Epub 2023 Jan 18.
2
Considerations for transferability of health technology assessments: a scoping review of tools, methods, and practices.考虑健康技术评估的可转移性:工具、方法和实践的范围综述。
Int J Technol Assess Health Care. 2022 Nov 2;38(1):e78. doi: 10.1017/S026646232200321X.
3
[Health technology assessment report: Computer-assisted Pap test for cervical cancer screening].[卫生技术评估报告:用于宫颈癌筛查的计算机辅助巴氏试验]
Epidemiol Prev. 2012 Sep-Oct;36(5 Suppl 3):e1-43.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Health technology assessment of biosimilars worldwide: a scoping review.全球生物类似药的卫生技术评估:一项范围综述
Health Res Policy Syst. 2020 Aug 26;18(1):95. doi: 10.1186/s12961-020-00611-y.
6
Guidance on review type selection for health technology assessments: key factors and considerations for deciding when to conduct a de novo systematic review, an update of a systematic review, or an overview of systematic reviews.健康技术评估中审查类型选择指南:决定何时进行全新系统评价、系统评价更新或系统评价概述的关键因素和考虑因素。
Syst Rev. 2022 Sep 27;11(1):206. doi: 10.1186/s13643-022-02071-7.
7
Methods for the health technology assessment of complex interventions: A scoping review.复杂干预措施的卫生技术评估方法:一项范围综述
PLoS One. 2025 Mar 14;20(3):e0315381. doi: 10.1371/journal.pone.0315381. eCollection 2025.
8
Are current clinical studies on artificial intelligence-based medical devices comprehensive enough to support a full health technology assessment? A systematic review.基于人工智能的医疗器械的当前临床研究是否足够全面,足以支持全面的健康技术评估?系统评价。
Artif Intell Med. 2023 Jun;140:102547. doi: 10.1016/j.artmed.2023.102547. Epub 2023 Apr 23.
9
[How can the impact of Health Technology Assessment (HTA) in the Austrian healthcare system be assessed? Design of a conceptual framework].[如何评估卫生技术评估(HTA)在奥地利医疗保健系统中的影响?一个概念框架的设计]
Gesundheitswesen. 2012 Apr;74(4):257-65. doi: 10.1055/s-0030-1270503. Epub 2011 Jan 25.
10
Real-world data: a comprehensive literature review on the barriers, challenges, and opportunities associated with their inclusion in the health technology assessment process.真实世界数据:纳入卫生技术评估过程中相关障碍、挑战和机遇的全面文献综述。
J Pharm Pharm Sci. 2024 Feb 28;27:12302. doi: 10.3389/jpps.2024.12302. eCollection 2024.

引用本文的文献

1
Integration of Generative AI with Human Expertise in HEOR: A Hybrid Intelligence Framework.生成式人工智能与药物卫生技术评估中的人类专业知识的整合:一种混合智能框架。
Adv Ther. 2025 Jun 25. doi: 10.1007/s12325-025-03273-w.
2
How was published evidence used in model-based cost - utility analysis for lung cancer?已发表的证据如何用于肺癌的基于模型的成本效益分析?
Health Econ Rev. 2025 Jun 16;15(1):50. doi: 10.1186/s13561-025-00651-6.
3
The Use of EQ-5D in the Middle East and North Africa Region: A Systematic Literature Review.EQ-5D在中东和北非地区的应用:一项系统文献综述

本文引用的文献

1
Development and implementation of a customised rapid syndromic diagnostic test for severe pneumonia.针对重症肺炎的定制化快速综合征诊断测试的开发与实施
Wellcome Open Res. 2022 Oct 12;6:256. doi: 10.12688/wellcomeopenres.17099.3. eCollection 2021.
2
A Conceptual Framework for Life-Cycle Health Technology Assessment.生命周期健康技术评估的概念框架。
Value Health. 2022 Jul;25(7):1116-1123. doi: 10.1016/j.jval.2021.11.1373. Epub 2022 Feb 4.
3
Systemic Immunomodulatory Treatments for Atopic Dermatitis: Update of a Living Systematic Review and Network Meta-analysis.
Pharmacoeconomics. 2025 May 10. doi: 10.1007/s40273-025-01483-2.
4
Navigating barriers to health technology assessment development in Iran: a qualitative exploration of stakeholder perspectives.应对伊朗卫生技术评估发展的障碍:对利益相关者观点的定性探索。
Arch Public Health. 2025 Mar 27;83(1):83. doi: 10.1186/s13690-025-01566-8.
5
Enhancing systematic literature reviews with generative artificial intelligence: development, applications, and performance evaluation.利用生成式人工智能加强系统文献综述:开发、应用及性能评估
J Am Med Inform Assoc. 2025 Apr 1;32(4):616-625. doi: 10.1093/jamia/ocaf030.
6
A Framework for Using Cost-effectiveness Analysis to Support Pricing and Reimbursement Decisions for New Pharmaceuticals in a Context of Evolving Treatments, Prices, and Evidence.在治疗方法、价格和证据不断演变的背景下,利用成本效益分析支持新药品定价和报销决策的框架。
Pharmacoeconomics. 2025 Apr;43(4):363-373. doi: 10.1007/s40273-024-01450-3. Epub 2024 Dec 31.
7
Ethical challenges for Health Technology Assessment (HTA) in the evolving evidence landscape.不断变化的证据格局下,卫生技术评估(HTA)面临的伦理挑战。
Int J Technol Assess Health Care. 2024 Nov 4;40(1):e39. doi: 10.1017/S0266462324000394.
8
A Prototype Software Framework for Transferable Computational Health Economic Models and Its Early Application in Youth Mental Health.用于可转移计算健康经济模型的原型软件框架及其在青少年心理健康中的早期应用。
Pharmacoeconomics. 2024 Aug;42(8):833-842. doi: 10.1007/s40273-024-01378-8. Epub 2024 May 20.
9
An operationalization framework for lifecycle health technology assessment: a Health Technology Assessment International Global Policy Forum Task Force report.生命周期健康技术评估的实施框架:健康技术评估国际全球政策论坛工作组报告。
Int J Technol Assess Health Care. 2024 May 16;40(1):e45. doi: 10.1017/S0266462324000199.
10
Lifecycle HTA: promising applications and a framework for implementation. An HTAi Global Policy Forum Task Force report.生命周期健康技术评估:有前景的应用和实施框架。HTAi 全球政策论坛工作组报告。
Int J Technol Assess Health Care. 2024 May 10;40(1):e50. doi: 10.1017/S0266462324000187.
特应性皮炎的系统免疫调节治疗:更新的活系统评价和网络荟萃分析。
JAMA Dermatol. 2022 May 1;158(5):523-532. doi: 10.1001/jamadermatol.2022.0455.
4
Out of Date or Best Before? A Commentary on the Relevance of Economic Evaluations Over Time.过期还是最佳使用期?对经济评估随时间变化的相关性的评论。
Pharmacoeconomics. 2022 Mar;40(3):249-256. doi: 10.1007/s40273-021-01116-4. Epub 2021 Dec 6.
5
Assessing Technologies for COVID-19: What are the Challenges for Health Technology Assessment Agencies? Findings From a Survey and Roundtable Workshop.评估 COVID-19 相关技术:卫生技术评估机构面临的挑战有哪些?一项调查和专题研讨会的结果。
Pharmacoeconomics. 2021 Dec;39(12):1455-1463. doi: 10.1007/s40273-021-01097-4. Epub 2021 Oct 12.
6
Characterising long COVID: a living systematic review.描述长新冠:一项正在进行的系统综述。
BMJ Glob Health. 2021 Sep;6(9). doi: 10.1136/bmjgh-2021-005427.
7
Making health economic models Shiny: A tutorial.让健康经济模型变得出色:教程
Wellcome Open Res. 2020 Jul 31;5:69. doi: 10.12688/wellcomeopenres.15807.2. eCollection 2020.
8
Social, Behavioral, and Cultural factors of HIV in Malawi: Semi-Automated Systematic Review.马拉维艾滋病毒的社会、行为和文化因素:半自动系统评价。
J Med Internet Res. 2020 Aug 14;22(8):e18747. doi: 10.2196/18747.
9
Half of Cochrane reviews were published more than 2 years after the protocol.半数 Cochrane 综述在方案发布后超过 2 年才发表。
J Clin Epidemiol. 2020 Aug;124:85-93. doi: 10.1016/j.jclinepi.2020.05.011. Epub 2020 May 12.
10
Achieving Appropriate Model Transparency: Challenges and Potential Solutions for Making Value-Based Decisions in the United States.实现适当的模型透明度:在美国做出基于价值的决策所面临的挑战和潜在解决方案。
Pharmacoeconomics. 2019 Nov;37(11):1321-1327. doi: 10.1007/s40273-019-00832-2.